9.52MMarket Cap-1910P/E (TTM)
1.3200High1.1900Low66.03KVolume1.1900Open1.1600Pre Close84.35KTurnover1.15%Turnover RatioLossP/E (Static)7.44MShares3.400052wk High4.09P/B7.35MFloat Cap0.252852wk Low--Dividend TTM5.74MShs Float3.4000Historical High--Div YieldTTM11.21%Amplitude0.2528Historical Low1.2770Avg Price1Lot Size
Nexalin Technology Stock Forum
NEWS
Nexalin Technology, Inc. receives a new method of use patent for their non-invasive deep brain stimulation device, enabling treatment for anxiety, depression, and insomnia from the comfort of patients' homes. The patent covers the technology utilized in their Gen-3 HALO Clarity™ system, extending through 2040. CEO Mark White highlights the significance of the patent in enhancing the company's strategy and clinical data supporting the device's benefits. The Gen-3...
In a significant development for mental health treatment, US-based Nexalin Technology, Inc., a leading innovator in neurostimulation technology, has commenced sales of its Generation-2 (Gen-2) Neurostimulation Device to a new mental health center in Oman. $Nexalin Technology(NXL.US)$
https://stockregion.app/p/us-based-technology-company-commences
No comment yet